[1] 王政禄,丛文铭.肝移植常见肝脏恶性肿瘤的病理分类及其临床特点[J].实用器官移植电子杂志,2019,7(2):122-127.
[2] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J].International Journal of Cancer,2015,136(5):E359-E386.
[3] 徐秀红,姜赛龙,蒋春兰.超声弹性成像与常规超声诊断肝脏局灶性良恶性病变价值比较[J].实用肝脏病杂志,2017,20(5):629-630.
[4] Sporea I, Badea R, Popescu A, et al.Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions-a prospective multicenter study of its usefulness in clinical practice[J]. Ultraschall in der Medizin, 2014,35(3):259-266.
[5] Claudon M, Dietrich C F, Choi B I, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012[J].Ultrasound in Medicine & Biology, 2013,39(2):187-210.
[6] Jo P C, Jang H J, Burns P N,et al. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver:how I do it[J]. Radiology, 2017, 282(2):317-331.
[7] 潘建强,盛陈卓娅,张浩.原发性肝细胞癌微血管密度与其超声造影血流灌注量参数的相关性[J].世界华人消化杂志,2019,27(9):565-569.
[8] 王鑫.声诺维超声造影中的不良反应与安全管理对策[J].中医药管理杂志,2018,26(9):137-139.
[9] 黄泽萍,王平,郑荣琴,等.常规超声检查与超声造影对肝脏局灶性病变检出能力的比较[J].中华肝脏外科手术学电子杂志,2013,2(4):240-244.
[10] 张岱,叶兆祥,魏玺,等.超声造影在肝脏局灶性病变中的应用价值[J].中国中西医结合急救杂志, 2017,24(5):523-526.
[11] 许戈良.肝癌血流动力学改变及其意义[J].中华肝脏外科手术学电子杂志,2018, 7(2):100-102.
[12] Burrowes D P,Medellin A,Harris A C,et al.Contrast-enhanced US approach to the diagnosis of focal liver masses[J]. Radiographics, 2017,37(5):1388-1400.
[13] Maruyama H,Sekimoto T,Yokosuka O.Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma:evidence from a 10-year experience[J]. Journal of Gastroenterology, 2016, 51(5):421-433.
[14] 骆雁翎,熊文文,张迎春,等.不同分化程度肝癌患者的超声造影参数分析[J].医学临床研究, 2017,34(2):381-383.
[15] Wildner D,Bernatik T,Greis C, et al. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients-early or late washout matters:a subanalysis of the DEGUM multicenter trial[J].Ultraschall in der Medizin-European Journal of Ultrasound, 2015, 36(2):132-139.
[16] Yue W W,Wang S,Xu H X,et al.Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer[J].Clinical Hemorheology and Microcirculation,2016,64(2):177-188.
[17] Chien J, Liu J, Lee M H,et al. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis[J].Journal of Gastroenterology and Hepatology, 2016,31:1971-1977.
[18] Kong W T, Ji Z B, Wang W P, et al. Evaluation of liver metastases using contrast-enhanced ultrasound:enhancement patterns and inflfluencing factors[J]. Gut and Liver,2016,10(2):283-287. |